Accuray develops and sells radiation therapy systems and software for delivering precise cancer and tumor treatments in hospitals and standalone treatment facilities worldwide. The company's core offerings include the CyberKnife robotic stereotactic radiosurgery platform and the TomoTherapy integrated delivery system with helical CT imaging, along with treatment planning and data management software that work across its delivery platforms. The business generates revenue primarily from equipment sales and software licensing, supplemented by ongoing customer support services including warranty coverage, installation, training, and professional services. Accuray competes with established radiotherapy manufacturers by offering advantages including robotic architecture with real-time motion tracking, integrated imaging capabilities, shorter treatment times, and modular system design.